Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in the field of urology

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Advances have been made in every aspect of urology that strengthen the scientific underpinning of current urologic practices and that hopefully will encourage further scientific investigation into the source, mechanisms, and cure of urologic diseases. This article reviews some of the advances that have been detailed in the recent urologic literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Turner TT: Physician-scientists in urology and the urology research programs that train them. J Urol 2004, 171:1979–1981.

    Article  PubMed  CAS  Google Scholar 

  2. Pareek G, Shevchuk M, Armenakas NA, et al.: The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol 2003, 169:20–23.

    Article  PubMed  CAS  Google Scholar 

  3. Nishizawa K, Kobayashi T, Watanabe J, Ogura K: Interstitial laser coagulation of the prostate for management of acute urinary retention. J Urol 2003, 170:879–882.

    Article  PubMed  Google Scholar 

  4. Corica AG, Qian J, Ma J, et al.: Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatment. J Urol 2003, 170:874–878.

    Article  PubMed  Google Scholar 

  5. Brock G, Nehra A, Lipshultz LI, et al.: Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003, 170:1278–1283. Vardenafil represents a new pharmaceutical option for the treatment of erectile dysfunction after radical retropubic prostatectomy.

    Article  PubMed  CAS  Google Scholar 

  6. Martinez R, Puigvert A, Pomerol JM, et al.: Clinical experience with apomorphine hydrochloride: the first 107 patients. J Urol 2003, 170:2352–2355.

    Article  PubMed  CAS  Google Scholar 

  7. Gontero P, Fontana F, Bagnasacco A, et al.: Is there an optimal time for intracavernous prostaglandin E1 rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol 2003, 169:2166–2169.

    Article  PubMed  Google Scholar 

  8. Manasia P, Pomerol J, Ribe N, et al.: Comparison of the efficacy and safety of 90-mg versus 20-mg fluoxetine in the treatment of premature ejaculation. J Urol 2003, 170:164–165.

    Article  PubMed  CAS  Google Scholar 

  9. Kuo HC: Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 2003, 170:835–839.

    Article  PubMed  Google Scholar 

  10. Abrams P, Amarenco G, Bakke A, et al.: Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol 2003, 170:1242–1251.

    Article  PubMed  Google Scholar 

  11. Kuo HC: Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003, 170:1908–1912.

    Article  PubMed  CAS  Google Scholar 

  12. Quek ML, Ginsberg DA: Long-term urodynamics follow-up of bladder augmentation for neurogenic bladder. J Urol 2003, 169:195–198.

    Article  PubMed  Google Scholar 

  13. Ninkovic M, Stenzl A, Schwabegger A, et al.: Free neurovascular transfer of latisstmus dorsi muscle for the treatment of bladder acontractility: II. Clinical results. J Urol 2003, 169:1379–1383.

    Article  PubMed  CAS  Google Scholar 

  14. Dmochowski RR, Avon M, Ross J, et al.: Transvaginal radio frequency treatment of the endopelvic fascia: a prospective evaluation for the treatment of genuine stress urinary incontinence. J Urol 2003, 169:1028–1032.

    Article  PubMed  Google Scholar 

  15. Cheah PY, Liong ML, Yuen KH, et al.: Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo-controlled trial [see comment]. J Urol 2003, 169:592–596.

    Article  PubMed  CAS  Google Scholar 

  16. Nickel JC, Pontari M, Moon T, et al.: A randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis [see comment]. J Urol 2003, 169:1401–1405.

    Article  PubMed  CAS  Google Scholar 

  17. Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study [see comment]. J Urol 2003, 169:1369–1373.

    Article  PubMed  Google Scholar 

  18. Corman JM, McClure D, Pritchett R, et al.: Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003, 169:2200–2202.

    Article  PubMed  Google Scholar 

  19. Erickson BA, Austin JC, Cooper CS, Boyt MA: Polyethylene glycol 3350 for constipation in children with dysfunctional elimination. J Urol 2003, 170:1518–1520.

    Article  PubMed  CAS  Google Scholar 

  20. Wallis MC, Brown DH, Jayanthi VR, Koff SA: A novel technique for ureteral catheterization and/or retrograde ureteroscopy after cross-trigonal ureteral reimplantation. J Urol 2003, 170:1664–1666.

    Article  PubMed  Google Scholar 

  21. Diamond DA, Caldamone AA, Bauer SB, Retik AB: Mechanisms of failure of endoscopic treatment of vesicoureteral reflux based on endoscopic anatomy. J Urol 2003, 170:1556–1559.

    Article  PubMed  Google Scholar 

  22. Solari V, Piotrowska AP, Cascio S, et al.: Cyclooxygenase-2 up-regulation in reflux nephropathy. J Urol 2003, 170:1624–1627.

    Article  PubMed  CAS  Google Scholar 

  23. Cheng EY, Kropp BP, Pope JC IV, Brock JW III: Proximal division of the urethral plate in staged hypospadias repair. J Urol 2003, 170:1580–1584. This is a novel modification of the Snodgrass technique for the staged proximal hypospadias repair.

    Article  PubMed  Google Scholar 

  24. Pak CY, Heller HJ, Pearle MS, et al.: Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions [see comment]. J Urol 2003, 169:465–469.

    Article  PubMed  CAS  Google Scholar 

  25. Traxer O, Huet B, Poindexter J, et al.: Effect of ascorbic acid consumption on urinary stone risk factors [see comment]. J Urol 2003, 170:397–401.

    Article  PubMed  CAS  Google Scholar 

  26. Cheung MC, Lee F, Leung YL, et al.: A prospective, randomized controlled trial on ureteral stenting after ureteroscopic holmium laser lithotripsy. J Urol 2003, 169:1257–1260.

    Article  PubMed  CAS  Google Scholar 

  27. Gill IS, Matin SF, Desai MM, et al.: Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 2003, 170:64–68.

    Article  PubMed  Google Scholar 

  28. El-Kassaby AW, Retik AB, Yoo JJ, Atala A: Urethral stricture repair with an off-the-shelf collagen matrix. J Urol 2003, 169:170–173.

    Article  PubMed  CAS  Google Scholar 

  29. Shah DK, Paul EM, Badlani GH, North American Study Group: 11-year outcome analysis of endourethral prosthesis for the treatment of recurrent bulbar urethral stricture. J Urol 2003, 170:1255–1258.

    Article  PubMed  Google Scholar 

  30. Evans LA, Ferguson KH, Foley JP, et al.: Fibrin sealant for the management of genitourinary injuries, fistulas, and surgical complications [see comment]. J Urol 2003, 169:1360–1362.

    Article  PubMed  CAS  Google Scholar 

  31. Roberts WW, Platz EA, Walsh PC: Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol 2003, 169:512–516.

    Article  PubMed  Google Scholar 

  32. Freedland SJ, deGregorio F, Sacoolidge JC, et al.: Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. J Urol 2003, 169:1325–1330.

    Article  PubMed  CAS  Google Scholar 

  33. Khan MA, Partin AW, Rittenhouse HG, et al.: Evaluation of proprostate-specific antigen for early detection of prostate cancer in men with a total prostate-specific antigen range of 4.0 to 10.0 ng/mL. J Urol 2003, 170:723–726.

    Article  PubMed  CAS  Google Scholar 

  34. Catalona WJ, Bartsch G, Rittenhouse HG, et al.: Serum pro prostate-specific antigen improves cancer detection compared to free and complexed prostate-specific antigen in men with prostate specific-antigen 2 to 4 ng/mL. J Urol 2003, 170:2181–2185.

    Article  PubMed  CAS  Google Scholar 

  35. Khan MA, Carter HB, Epstein JI, et al.: Can prostate-specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J Urol 2003, 170:2274–2278.

    Article  PubMed  Google Scholar 

  36. Guillonneau B, el-Fettouh H, Baumert H, et al.: Laparoscopic radical prostatectomy: oncological evaluation after 1000 cases a Montsouris Institute. J Urol 2003, 169:1261–1266.

    Article  PubMed  CAS  Google Scholar 

  37. Vallancien G, Gupta R, Cathelineau X, et al.: Initial results of salvage laparoscopic radical prostatectomy after radiation failure [see comment]. J Urol 2003, 170:1838–1840.

    Article  PubMed  Google Scholar 

  38. Rassweiler J, Seemann O, Schulze M, et al.: Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol 2003, 169:1689–1693. This study highlights the benefits of laparoscopic prostatectomy, but also the steep learning curve associated with the procedure.

    Article  PubMed  Google Scholar 

  39. Guillonneau B, Gupta R, El Fettouh H, et al.: Laparoscopic [correction of laproscopic] management of rectal injury during laparoscopic [correction of laproscopic] radical prostatectomy. J Urol 2003, 169:1694–1696.

    Article  PubMed  CAS  Google Scholar 

  40. Critz FA, Williams WH, Levinson AK, et al.: Prostatespecific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. J Urol 2003, 170:1864–1867.

    Article  PubMed  Google Scholar 

  41. Ockrim JL, Lalani EN, Laniado ME, et al.: Transdermal estradiol therapy for advanced prostate cancer: forward to the past [see comment]? J Urol 2003, 169:1735–1737.

    Article  PubMed  CAS  Google Scholar 

  42. Beer TM, Garzotto M, Eilers KM, Lemmon D: Phase-II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy [see comment]. J Urol 2003, 169:1738–1741.

    Article  PubMed  CAS  Google Scholar 

  43. Smith MR, Eastham J, Gleason DM, et al.: Randomized, controlled trial of zoledronic acid to prevent bone loss in men receiving androgen-deprivation therapy for nonmetastatic prostate cancer. J Urol 2003, 169:2008–2012.

    Article  PubMed  CAS  Google Scholar 

  44. Bander NH, Trabulsi EJ, Kostakoglu L, et al.: Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostatespecific membrane antigen. J Urol 2003, 170:1717–1721.

    Article  PubMed  CAS  Google Scholar 

  45. Nadler RB, Kim SC, Rubenstein JN, et al.: Laparoscopic renal cryosurgery: the Northwestern experience [see comment]. J Urol 2003, 170:1121–1125.

    Article  PubMed  Google Scholar 

  46. Johnson DB, Taylor GD, Lotan Y, et al.: The effects of radio frequency ablation on renal function and blood pressure. J Urol 2003, 170:2234–2236.

    Article  PubMed  Google Scholar 

  47. Wu F, Wang ZB, Chen WZ, et al.: Preliminary experience using high-intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol 2003, 170:2237–2240.

    Article  PubMed  Google Scholar 

  48. Retz M, Lehmann J, Amann E, et al.: Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor. J Urol 2003, 169:86–89.

    Article  PubMed  CAS  Google Scholar 

  49. Pfister C, Chautard D, Devonec M, et al.: Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study [see comment]. J Urol 2003, 169:921–924.

    Article  PubMed  Google Scholar 

  50. Hofmann T, Riesenberg R, Buchner A, et al.: Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators. J Urol 2003, 169:1303–1007.

    Article  PubMed  CAS  Google Scholar 

  51. Marti A, Jichlinski P, Lange N, et al.: Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003, 170:428–432.

    Article  PubMed  CAS  Google Scholar 

  52. Stein JP, Cai J, Groshen S, Skinner DG: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003, 170:35–41. Lymph node density (total number of positive lymph nodes/total number of lymph nodes removed) appears to be a more standardized prognostic indicator for patients with bladder cancer and lymph node tumor involvement.

    Article  PubMed  Google Scholar 

  53. Chin A, Ragavendra N, Hilborne L, Gritsch HA: Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J Urol 2003, 170:380–383.

    Article  PubMed  Google Scholar 

  54. Shokeir AA, Gad HM, el-Diasty T: Role of radioisotope renal scans in the choice of nephrectomy side in live kidney donors. J Urol 2003, 170:373–376.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wake Forest Institute for Regenerative Medicine and Department of Urology, Wake Forest University School of Medicine, Medical Center Blvd., 27157, Winston Salem, NC, USA

    Anthony Atala MD

Authors
  1. Chester J. Koh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Atala MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Atala MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koh, C.J., Atala, A. Recent advances in the field of urology. Curr Urol Rep 7, 43–49 (2006). https://doi.org/10.1007/s11934-006-0037-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-006-0037-6

Keywords

Search

Navigation